WPRIM Management System> DCMS> Journal of Gynecologic Oncology> 2009> 20> 3

Volume: 20 Issue: 3

1. ERRATUM: Role of high risk-human papilloma virus test in the follow-up of patients who underwent conization of the cervix for cervical intraepithelial neoplasia. Page:200—200
2. In reply: Different role of secondary cytoreductive surgery by surgeon's experience and hospital facility. Page:199—199
3. Prognostic factors of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer. Page:198—198
4. A single horn endometrial carcinoma of a uterus bicornis unicollis. Page:195—197
5. A case of non-gestational choriocarcinoma arising in the ovary of a postmenopausal woman. Page:192—194
6. A case of neutrophilia related to a cytokine-producing relapsed squamous cell carcinoma of the uterine cervix arising from the rectovaginal septum. Page:187—191
7. Premenopausal early-stage endometrial carcinoma patients with low CA-125 levels and low tumor grade may undergo ovary-saving surgery. Page:181—186
8. Clinical analysis of intra-operative frozen section proven borderline tumors of the ovary. Page:176—180
9. Correlation between preoperative serum levels of five biomarkers and relationships between these biomarkers and cancer stage in epithelial overian cancer. Page:169—175
10. Treatment of the patients with abnormal cervical cytology: a "see-and-treat" versus three-step strategy. Page:164—168
11. Prognostic factors in adult granulosa cell tumors of the ovary: a retrospective analysis of 80 cases. Page:158—163
12. Acute toxicity of cyclooxygenase-2 inhibitor rofecoxib as a radiosensitizer for concurrent chemoradiation in the treatment of uterine cervical cancer. Page:151—157
13. Prognostic significance of neutropenia during adjuvant concurrent chemoradiotherapy in early cervical cancer. Page:146—150
14. JSGO's 46th Biannual Meeting, July 10-12, 2009. Page:145—145
15. Recent advances of robotic surgery and single port laparoscopy in gynecologic oncology. Page:137—144
16. International Federation of Gynecology and Obstetrics (FIGO) staging system revised: what should be considered critically for gynecologic cancer?. Page:135—136